NCT05065060 Parkinson Progression Marker Initiative Online (PPMI Online)
| NCT ID | NCT05065060 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Michael J. Fox Foundation for Parkinson's Research |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 500,000 participants |
| Start Date | 2021-07-28 |
| Primary Completion | 2041-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500,000 participants in total. It began in 2021-07-28 with a primary completion date of 2041-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal of better understanding risk and predictive factors for PD. PPMI Online is part of the broader Parkinson Progression Marker Initiative aimed at identifying markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
Eligibility Criteria
Inclusion Criteria: * Parkinson Disease (PD) Participants: * Male or female age 18 years or older. * Has received a diagnosis of Parkinson's disease Participants without PD: * Male or female age 18 years or older. * Has not received a diagnosis of Parkinson's disease
Contact & Investigator
Caroline Tanner, MD, PhD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT05065060 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05065060 currently recruiting?
Yes, NCT05065060 is actively recruiting participants. Contact the research team at info@ppmionline.org for enrollment information.
Where is the NCT05065060 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT05065060 clinical trial?
NCT05065060 is sponsored by Michael J. Fox Foundation for Parkinson's Research. The principal investigator is Caroline Tanner, MD, PhD at University of California, San Francisco. The trial plans to enroll 500,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.